Drawing for MOOTRITION

USPTO serial 98150426

MOOTRITION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RINGLE, JAMES W
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MOOTRITION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark D. Swanson

MARK D. SWANSON PAULEY ERICKSON & SWANSON10 EXECUTIVE COURTSUITE 3SOUTH BARRINGTON, IL 60010

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations for the reduction of methanogenesis in ruminants, for use as disinfectants for hooves, for use in promoting well-being of animals in the nature of complementary and medicated animal feed, for the treatment and prevention of infectious poditis in animals; dietetic food and substances adapted for veterinary use, namely, dietary supplements for animals and medicated animal feed; dietary supplements for animals; disinfectant; preparations for destroying vermin; fungicides; herbicides; anthelmintics; antiparasitic preparations; biological preparations for veterinary purposes, namely, biological tissue cultures; biological preparations for medical purposes, namely, biological tissue cultures; chemical preparations in the nature of powder and liquid form containing combinations of plant extracts, Allicin, garlic extracts, compounds extracted and derived from garlic and polyphenols for veterinary purposes; chemical reagents for medical purposes; chemical reagents for veterinary purposes; chemical preparations containing combinations of plant extracts, Allicin, garlic extracts, compounds extracted and derived from garlic and polyphenols for medical purposes, namely, for the reduction of methanogenesis in ruminants, as disinfectants for hooves and for use in promoting well-being of animals, for the treatment and prevention of infectious poditis in animals; chemico-pharmaceutical preparations for the reduction of methanogenesis in ruminants, the reduction of greenhouse gas emissions produced by ruminants, use as disinfectant for hooves, promoting the general well-being of animals in the nature of complementary and medicated animal feed, the treatment and prevention of diseases in animals such as infectious poditis; chemical preparations to treat mildew; chemical preparation to treat wheat blight; chemical preparation to treat wheat smut; fumigating pastilles; fumigating sticks; fumigation preparation for medical purposes; lotions for veterinary purposes for topical use to treat skin conditions, skin diseases and lesions; lotions for medical purposes for use in promoting general well-being of animals, namely, pharmaceutical skin lotions, for the treatment and prevention of diseases in animals, namely, for ulcerating wounds, skin diseases, skin conditions and lesions; disposable wipes in the nature of tissues impregnated with pharmaceutical lotions for the treatment and prevention of ulcerating wounds and infectious diseases; medicinal herbs; medicinal infusions for the treatment and prevention of ulcerating wounds and infectious diseases; medicinal oils; parasiticides; slug exterminating preparations; plant extracts for nutraceutical use, namely, plant extracts for promoting immune health and heart health in animals; plant extracts for dietetic use, namely, plant extracts for use for promoting immune health and heart health in animals; plant extracts for medical use; plant extracts for nutritional purposes for promoting immune health and heart health in animals; pesticides; agricultural and domestic biopesticidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 3, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 26, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 26, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 26, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 26, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 21, 2024DOCKASSIGNED TO EXAMINER—
Sep 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 29, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance